US Patent Issued to PEKING UNIVERSITY on March 31 for "Pt(IV) chemotherapeutic prodrug and controlled release thereof for treatment of tumors" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,111, issued on March 31, was assigned to PEKING UNIVERSITY (Beijing).

"Pt(IV) chemotherapeutic prodrug and controlled release thereof for treatment of tumors" was invented by Zhibo Liu (Beijing) and Qunfeng Fu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a Pt(IV) complex. As a prodrug, the Pt(IV) complex is activated by irradiation to release a Pt(II) complex for the treatment of tumors. Also provided is a pharmaceutical composition including the Pt(IV) complex, and the use of the Pt(IV) complex in the preparation of a drug for treating tumors by means of irradiation activation. Further provided is a kit including the Pt(IV) ...